TABLE 22Proportion of patients with ALD in whom FibroScan was either thought inappropriate or was unsuccessful

StudyExclusion criteria that might affect FibroScan performanceFibroScan unsuccessful: patients with ALD (%)Reasons for failure
Janssens 2010117None reported11/250 (4.4)Obesity or ascites
Kim 2009127BMI ≥ 30; probability of successful testing < 30%: 6/51 (11.8%) excluded for these reasonsNone reportedNone reported
Lemoine 200897None reportedNone reportedNone reported
Melin 2005122None reported18/245 (7.3)Obesity
Mueller 2010118None reported5/106 (4.7)Measurements invalid or interquartile range > 40%
Nahon 2008128None reported15/174 (8.6)Results inadequate; no reason given
Nguyen-Khac 2008132Failure to obtain valid measurements: 2/105 (1.9%) excluded, no more specific reason givenNone reportedNone reported
Nguyen-Khac 2009130None reportedNone reportedNone reported

From: 4, Assessment of clinical effectiveness

Cover of Non-Invasive Diagnostic Assessment Tools for the Detection of Liver Fibrosis in Patients with Suspected Alcohol-Related Liver Disease: A Systematic Review and Economic Evaluation
Non-Invasive Diagnostic Assessment Tools for the Detection of Liver Fibrosis in Patients with Suspected Alcohol-Related Liver Disease: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 16.4.
Stevenson M, Lloyd-Jones M, Morgan MY, et al.
Southampton (UK): NIHR Journals Library; 2012 Feb.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.